Thalidomide and lung cancer

I have read in the paper about a study for thalidomide and small cell lung cancer. I was wondering where I could find more information?

A few trials have tested thalidomide for small cell lung cancer (SCLC). Some used it alongside chemotherapy. Thalidomide is what we call an anti angiogenic drug. Angiogenesis means the growth of new blood vessels. Thalidomide is a drug that stops new blood vessels from forming. Cancers need to grow their own blood vessels as they get bigger. Without its own blood supply, a cancer cannot continue to grow.

Unfortunately the trials so far found that adding thalidomide to chemotherapy did not help patients with advanced non small cell lung cancer to live longer. But thalidomide is being used as a treatment for other kinds of cancer. You can find information about thalidomide in the cancer drugs section.

You can find out about other trials for lung cancer on our clinical trials database. Please bear in mind that to be able to take part in a clinical trial, your cancer specialist has to refer you to the trials team.